Ananth Charya

Also affiliated with University of Maryland Medical Center, National Heart Lung and Blood Institute, Digital Research Alliance of Canada

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury”.

Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury

JCI Insight(2021)10.1172/jci.insight.147610

N/A

0DataRank · unranked

153 citations

Takayuki Tsuji, Fayaz Seifuddin, Moon Kyoo Jang, Peter S.T. Yuen, Hyesik Kong +10 more

Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients

American Journal of Transplantation(2022)10.1111/ajt.17039

N/A

0DataRank · unranked

34 citations

Rohan Meda, Sheng Fu, Kai Yu, Moon Kyoo Jang, Ananth Charya +10 more

Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories

The Journal of Heart and Lung Transplantation(2022)10.1016/j.healun.2022.09.012

N/A

0DataRank · unranked

19 citations

Ileana L. Ponor, A. Cochrane, Deborah J. Levine, Mary Carmelle Philogene, Yi‐Ping Fu +15 more

The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease

Blood Advances(2022)10.1182/bloodadvances.2021006885

N/A

0DataRank · unranked

16 citations

Ananth Charya, Michael B. Keller, Arlene Sirajuddin, Yi‐Ping Fu, Noa G. Holtzman +3 more

Laboratory Considerations for Successful Xenotransplantation in Humans

Clinical Chemistry(2022)10.1093/clinchem/hvac150

N/A

0DataRank · unranked

3 citations

Ananth Charya, T. Andargie, Sean Agbor-Enoh, Michael Keller

Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death

American Journal of Transplantation(2023)10.1016/j.ajt.2022.12.019

N/A

0DataRank · unranked

22 citations

Song Yang, Lucia Ponor, Ann Bon, A. Cochrane, Mary Carmelle Philogene +12 more

Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection

The Journal of Heart and Lung Transplantation(2023)10.1016/j.healun.2023.11.008

N/A

0DataRank · unranked

7 citations

Xin Tian, Moon Kyoo Jang, Rohan Meda, Ananth Charya, Deniz Ozisik +10 more

Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease

The Journal of Heart and Lung Transplantation(2024)10.1016/j.healun.2024.04.064

N/A

0DataRank · unranked

14 citations

David Newman, Muhtadi Alnababteh, Lucia Ponor, Pali D. Shah, Joby Mathew +12 more

Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure

The Journal of Heart and Lung Transplantation(2025)10.1016/j.healun.2025.03.015

N/A

0DataRank · unranked

6 citations

David Newman, Muhtadi Alnababteh, Ann Bon, Lucia Ponor, Pali D. Shah +14 more

Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction

The Journal of Heart and Lung Transplantation(2025)10.1016/j.healun.2025.06.012

N/A

0DataRank · unranked

6 citations

Junfeng Sun, Rohan Meda, Lucia Ponor, Pali D. Shah, Joby Mathew +11 more

Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantation

American Journal of Transplantation(2025)10.1016/j.ajt.2025.04.011

N/A

0DataRank · unranked

5 citations

Moon Kyoo Jang, Hyesik Kong, Woojin Park, Xin Tian, Michael Keller +11 more